RAUGEI, ANDREA
RAUGEI, ANDREA
Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study.
1994 Neri B; Nicita G; Stomaci N; Gemelli M; Intini C; Fiorelli C; Mottola A; Paoletti M; Ponchietti R; Raugei A; Trippitelli A; Vici I; Villari D; Grechi G
Endoluminal instillation of Epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours
1996 R. Ponchietti; B. Neri; F. Di Loro; A. Raugei
Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
2007 B. Neri; L. Vannini; C. Giordano; R. Grifoni; P. Pantaleo; V. Baldazzi; A. Crisci; A. Lapini; A. Raugei; M. Carini
Long-term biochemotherapy with cytokines and gencitabine in metastatic renal cell cancer: a phase II study
2003 B.Neri; C.Fulignati; M. Turrini; A. Della Melina; V. Di Cello; G. Nicita; A. Raugei; D. Villari; G.L.Pellegrini; G.Cini
Melatonin as Biological Response Modifier in Cancer Patients
1998 B. Neri; V. de Leonardis; M. Gemelli; F. Di Loro; R. Ponchietti; A. Raugei; G. Cini
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer.
2002 Neri B;Doni L;Gemelli MT;Fulignati C;Turrini M;Di Cello V;Dominici A;Maleci M;Mottola A;Ponchietti R;Raugei A;Valsuani G;Cini G
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer
2009 B. Neri;E.Molinara;P.Pantaleo;S.Rangan;A.Crisci; A.Della Melina;A.Raugei;D.Villari;G.Nicita
Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer.
1997 B Neri; G Barbagli; P Bellesi; R Di Loro; V Lombardi; C Lombardo; T Magrini; A Mottola; G Nicita; E Palminteri; R Ponchietti; A Raugei; C Intini
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial
2005 B. Neri; G. Cipriani; C. Fulignati; M. Turrini; R. Ponchietti; R. Bartoletti; A. Della Melina; V. Di Cello; D. Maleci; A. Raugei; D. Villari; G. Nicita
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cyclophosphamide, epidoxorubicin and Carboplatin as treatment for advanced-carcinoma of the bladder - a phase-ii study. | 1994 | Neri B; Nicita G; Stomaci N; Gemelli M; Intini C; Fiorelli C; Mottola A; Paoletti M; Ponchietti R; Raugei A; Trippitelli A; Vici I; Villari D; Grechi G | |
| Endoluminal instillation of Epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours | 1996 | R. Ponchietti; B. Neri; F. Di Loro; A. Raugei | |
| Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study | 2007 | B. Neri; L. Vannini; C. Giordano; R. Grifoni; P. Pantaleo; V. Baldazzi; A. Crisci; A. Lapini; A. Raugei; M. Carini | |
| Long-term biochemotherapy with cytokines and gencitabine in metastatic renal cell cancer: a phase II study | 2003 | B.Neri; C.Fulignati; M. Turrini; A. Della Melina; V. Di Cello; G. Nicita; A. Raugei; D. Villari; G.L.Pellegrini; G.Cini | |
| Melatonin as Biological Response Modifier in Cancer Patients | 1998 | B. Neri; V. de Leonardis; M. Gemelli; F. Di Loro; R. Ponchietti; A. Raugei; G. Cini | |
| Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer. | 2002 | Neri B;Doni L;Gemelli MT;Fulignati C;Turrini M;Di Cello V;Dominici A;Maleci M;Mottola A;Ponchietti R;Raugei A;Valsuani G;Cini G | |
| Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer | 2009 | B. Neri;E.Molinara;P.Pantaleo;S.Rangan;A.Crisci; A.Della Melina;A.Raugei;D.Villari;G.Nicita | |
| Weekly epidoxorubicin therapy in hormone-refractory metastatic prostate cancer. | 1997 | B Neri; G Barbagli; P Bellesi; R Di Loro; V Lombardi; C Lombardo; T Magrini; A Mottola; G Nicita; E Palminteri; R Ponchietti; A Raugei; C Intini | |
| Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial | 2005 | B. Neri; G. Cipriani; C. Fulignati; M. Turrini; R. Ponchietti; R. Bartoletti; A. Della Melina; V. Di Cello; D. Maleci; A. Raugei; D. Villari; G. Nicita |